期刊文献+

临床分离念珠菌的特征及耐药性研究

STUDY ON THE CHARACTERISTIC AND DRUG RESISTANCE OF CLINICAL ISOLATES OF CANDIDA ALBICANS
原文传递
导出
摘要 目的研究临床分离念珠菌的特征及其耐药性,为合理用药提供参考依据。方法采用真菌分离鉴定技术和药敏试验方法,对某医院住院患者临床送检标本进行念珠菌种类调查和耐药性分析。结果调查期间从该医院临床送检病原学标本中,共检出念珠菌497株,分离菌株数居前三位的科室是呼吸科、重症监护病房和神经内科。有54.33%的菌株分离自呼吸道标本,另有16.70%的标本为泌尿生殖道标本。临床分离的念珠菌主要是白色念珠菌,占62.78%,其次是光滑念珠菌。临床分离的念珠菌对5-氟胞嘧啶和两性霉素B敏感率较高,但耐药率呈现逐年增加趋势。结论临床分离的念珠菌多数为白色念珠菌,主要为呼吸道感染,对抗念珠菌药敏感率均在60%以上,但耐药性有增加趋势。 Objective To study the characteristics and drug resistance of clinical isolates of Candida albicans, and to provide reference for rational drug use. Methods Fungal isolation and identification and drug sensitive test methods were used to analyze fungal species and drug resistance of clinical samples in a hospital. Results During the period of investigation, there were 497 strains of fungi isolated from the hospital clinical laboratory pathogenic specimens. The number of top three in department were department of respiration, ICU and neural department of internal medicine. 54.33% strains were isolated from respiratory tract specimens, and 16.70% were isolated from Genitourinary tract specimens. Clinical isolated fungi was mainly Candida albicans, accounted for 62.78%, followed by Candida glabrata. Clinical isolated fungi was sensitive to 5 - fluorocytosine and amphoteriein B, but the resistance rate was increasing year by year. Conclusion Most clinical isolated fungi are Candida albicans, mainly for respiratory tract infection, and the antifungal drug sensitive rate is above 60%. But the resistance has increasing tendency.
出处 《中国消毒学杂志》 CAS 北大核心 2014年第10期1079-1081,共3页 Chinese Journal of Disinfection
基金 广东省医学科研基金项目(A2011212)
关键词 念珠菌 医院感染 分布特征 抗真菌药 耐药性 fungi nosocomial infection distribution character anti -fungi drug drug resistance
  • 相关文献

参考文献9

二级参考文献54

  • 1袁春雷,李介华,李冬秀,徐辉,梁金水.323株酵母样真菌的分离鉴定与耐药性分析[J].中国公共卫生,2004,20(1):98-98. 被引量:6
  • 2黄长武,李兴禄,邱君凤,谢敬.白色念珠菌在呼吸道中致病性的研究[J].中华医院感染学杂志,2004,14(7):721-723. 被引量:14
  • 3朱晓芳,章强强,蓝和魁,郭秀军,李莉,任大明,王家俊.白念珠菌临床分离株的基因分型及药物敏感性研究[J].扬州大学学报(农业与生命科学版),2004,25(4):82-84. 被引量:5
  • 4徐修礼,杨佩红,孙怡群,樊新.深部真菌感染的菌群分布及耐药性[J].中华医院感染学杂志,2007,17(3):349-351. 被引量:50
  • 5Scott LJ,Simpson D. Voriconazole:a review of its use in the management of invasive fungal infections[J]. Drugs, 2007,67 (2) :269-298.
  • 6Wada S, NiimiM, NiimiM, et al. Candida glabrata ATP-binding cassette transporters Cdrlp and Pdhlp espressed in a Saccharomyces cerevisiae steai deficient in membrane transporters show phorylation dependent pumping properties [J]. J Biolcham, 2002, 277 (48) : 46809.
  • 7Kontoyiannis DP, Lewis Antifungal drug resistance of pathogenic fungi [J]. Lancet, 2002, 359 (9312): 1135.
  • 8Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of eandidiasis: 2009 update by the Infection Diseases Society of America [J]. Clin Infection Dis, 2009, 48 (5): 503-535.
  • 9Chapman SW, Sullivan DC, Cleary JD. In search of the holy grail of antifungal therapy[ J]. Trans Am Clin Climatol Assoc, 2008,119 : 197-216.
  • 10Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infec- tion[J]. Lancet Infect Dis, 2011,11(2) :142-151.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部